Interventional Dexterity

A New Form of Catheter Control


The Project Moray Robotic Catheter System
The Moray Medical Robotic Catheter System in action

Moray Medical’s robotic system moves a cardiac catheter inside the beating heart of a patient with a dexterity, precision, and ease of use beyond what was previously possible. The reusable Moray Medical drive mechanism bends a single-use, proprietary Moray Medical catheter in different directions along its length — somewhat like an eel. Interventional cardiologists need this dexterity so they can treat hundreds of thousands of patients who are too frail to survive the trauma of open heart surgery. Moray Medical’s simple cardiac catheter system is driven without pull wires, motors, or magnets, relying instead on computer-controlled microfluidic pressure that is delivered from a smaller footprint than that of known analogous systems, allowing Moray Medical to bring robotic dexterity, precision, and ease-of-use to a range of therapies.

The Market Opportunity

The Project Moray Robotic Catheter System
The Moray Medical Robotic Catheter System

Put succinctly, Moray Medical’s eel-like dexterity and elegantly simple drive technology will fundamentally improve the way structural heart and other therapies are delivered. The “structural heart” field involves the use of catheter-based devices to remotely access (via the vasculature) and treat the tissues of the valves and other internal structural components of a beating heart. The structural heart market is currently one of the fastest growing medical device fields, and that growth is accelerating with emergence of the Transcatheter Mitral Valve Replacement (TMVR) and Transcatheter Mitral Valve repair (TMVr) markets. Mitral regurgitation (MR), or leakage of the mitral valve of the heart, affects millions of people. The current dramatic adoption rates for structural heart therapies, together with the billions of dollars invested over the last decade on TMVR implants for which no viable catheter-based delivery system is yet available, help validate the potential value of Moray Medical’s therapy delivery products. Moray Medical’s robotic catheter system will deliver structural heart and other interventional tools at a lower cost per patient than existing mechanical technologies. As a result, significant markets exist for both stand-alone Moray Medical systems and for Moray Medical catheters tailored for delivery of structural heart tools developed by the company’s strategic partners.



Graphic for Moray Medical's award as a MedTech Innovator

Moray Medical chosen as MedTech Innovator

Moray Medical is honored to be chosen from a pool of 1000+ applicants by MedTech Innovator, the premier nonprofit accelerator in the medical technology industry, as one of 50 leading medtech startups transforming the healthcare industry. Moray will participate in the 2020 Accelerator & Showcase program, a four-month event featuring the industry’s most transformative device, diagnostic, and digital health technologies from around the globe. As one of the selected up and coming startups, Moray will receive unparalleled visibility and access to leading manufacturers, providers, investors, and other industry stakeholders.

Gore Innovation's facility

Gore Innovation Center collaboration with Moray Medical

February 26, 2020 – The Gore Innovation Center today announced a collaboration with Moray Medical, a 2-year-old startup developing precision automated delivery systems for endovascular procedures. The collaboration is aimed at fundamentally improving the control and accuracy of minimally invasive interventional medical procedures.

Today, Moray Medical is leveraging the prototyping lab to deliver transformative breakthroughs at scale. The lab offers broad ideation, testing and manufacturing capabilities — including additive and subtractive manufacturing, wet chemistry, analytical tools, and more.

The Gore Innovation Center is an 11,000 square feet co-innovation space featuring a state-of-the-art prototyping lab. Startups, researchers, corporations and customers can collaborate with Gore innovators on difficult advanced materials challenges to create new business opportunities and value for all partners.


July 11, 2019 – An esteemed panel of subject matter experts, clinicians, and investors selected Moray Medical (then called Project Moray) as a Rosenman Innovator for its innovative technology and patient impact, digitizing the user interface of cardiac catheter systems to enable precise delivery of therapies within the beating hearts of millions of patients.

The UCSF Rosenman Institute, a health technology initiative at the University of California, San Francisco, provides selected startups with expertise and mentorship from stakeholders across the healthcare industry. Only 10 Rosenman Innovators are chosen per year. Eligible companies must be developing technologies in the medical device, diagnostics, and digital health spaces, and seeking funding from seed stage to Series A. More than 100 companies applied for the 2019 selection.